Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

Published:2014-01-08 Issue:6 Volume:29 Page:1429-1431
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Purdue M P,Lan Q,Kemp T J,Hildesheim A,Weinstein S J,Hofmann J N,Virtamo J,Albanes D,Pinto L A,Rothman N

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu20152.pdf

Reference15 articles.

1. Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA . Non-Hodgkin lymphoma. Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention. 3rd edn. Oxford University Press: New York, NY, USA, 2006, 898–918.

2. Gu Y, Shore RE, Arslan AA, Koenig KL, Liu M, Ibrahim S et al. Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control 2010; 21: 1323–1333.

3. Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY et al. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 2009; 114: 2730–2732.

4. Vermeulen R, Hosnijeh FS, Portengen L, Krogh V, Palli D, Panico S et al. Circulating soluble CD30 and future risk of lymphoma; evidence from two prospective studies in the general population. Cancer Epidemiol Biomarkers Prev 2011; 20: 1925–1927.

5. Purdue MP, Lan Q, Bagni R, Hocking WG, Baris D, Reding DJ et al. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer Res 2011; 71: 4898–4907.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes;Cancer Epidemiology, Biomarkers & Prevention;2022-11-21

2. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker;Frontiers in Immunology;2022-11-16

3. Circulating immune markers and risks of non‐Hodgkin lymphoma subtypes: A pooled analysis;International Journal of Cancer;2022-10-05

4. Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya;Frontiers in Immunology;2022-05-06

5. Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models;Artificial Cells, Nanomedicine, and Biotechnology;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3